DuPont falls on earnings, but investors might want to buy on weakness

The market didn't like DuPont's (DD) third-quarter earnings report, sending shares of the chemical giant down as much as three percent during Tuesday's session. This component of the Dow Jones Industrial Average ($INDU) easily beat Wall Street's profit estimate, but sales across all DuPont's businesses were down.

DuPont's stock has been a market beater so far this year, rising 37 percent to outpace the S&P 500 ($INX) by 15 percentage points. Perhaps today's stumble offers investors a chance to buy the blue chip on weakness. Shares go for just 16 times forward earnings, offering a discount of about 20 percent to the broader market. That's an intriguing relative valuation. Perhaps most attractive is DuPont's dividend. The share-price slide has boosted the yield to 4.8 percent.
Read Full Story
  • DJI26501.60-157.51-0.59%
    NASDAQ10911.59-274.00-2.45%
  • NIKKEI 22522977.13-354.81-1.52%
    Hang Seng24107.42-479.18-1.95%
    DAX11556.48-41.59-0.36%
  • USD (PER EUR)1.16-0.0029-0.24%
    USD (PER CHF)1.09-0.0014-0.13%
    JPY (PER USD)104.660.05200.05%
    GBP (PER USD)1.300.00280.22%

From Our Partners